A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00077870
Recruitment Status : Completed
First Posted : February 16, 2004
Last Update Posted : September 3, 2009
Information provided by:
Genentech, Inc.